Learn More
Medchemexpress LLC 1,1'-(4,4'-(((5-chloropyrimidine-2,4-diyl)bis(azanediyl))bis(3-methoxy-4,1-phenylene))bis(piperazine-4,1-diyl))diethanone | 1472795-20-2 | MFCD28133395 | 96.2% | 609.12 g·mol^-1 | C30H37ClN8O4 | 10MM 1ML

Supplier: Medchemexpress LLC HY1233110MM 1ML
KRCA-0008 is a selective dual inhibitor of anaplastic lymphoma kinase (ALK) and activated Cdc42-associated kinase 1 (ACK1/TNK2) with reported IC50 values of approximately 12 nM for ALK and 4 nM for ACK1. It is intended for preclinical research into oncogenic signalling and cancer biology and is supplied as a concentrated DMSO solution suitable for in vitro biochemical and cellular assays.
- Potent dual kinase inhibition with low nanomolar IC50 values.
- Suitable for biochemical and cellular assays.
- Provided as a 10 mM solution in DMSO for convenient dosing.
- High purity (≈96.2%) with stated stability and storage recommendations.
- Intended for research use only; not for human consumption.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.